Top insider buys: Aug 25 – Aug 31, 2025

The largest open-market purchases company insiders reported on SEC Form 4 between Aug 25 – Aug 31, 2025.

Week 35, 2025

#CompanyWho boughtSharesValueSource
1STSS

Sharps Technology Inc.

6 officers/directors

Cluster buy

Monroe Jason L., Crescenzo Andrew R., Hayes Robert Michael, Christiansen Soren Bo, DANNER PAUL K, Simpson Brenda Baird

720,000

$4.6M

SEC filings
2TPVG

TriplePoint Venture Growth BDC Corp.

2 officers/directors

Cluster buy

Labe James, Srivastava Sajal

406,302

$2.6M

SEC filings
3EMN

EASTMAN CHEMICAL CO

9 officers/directors

Cluster buy

SMITH BRIAN TRAVIS, Mink Kim Ann, BUTLER ERIC L, BEGEMANN BRETT D, Audia Damon J, McAlindon Julie A., LICH BRAD A, McLain William Thomas Jr., Costa Mark J

25,515

$1.7M

SEC filings
4EBC

Eastern Bankshares, Inc.

4 officers/directors

Cluster buy

Antonakes Steven Louis, Miller Quincy Lee, SHEAHAN DENIS K, Rivers Robert Francis

94,294

$1.6M

SEC filings
5COTY

COTY INC.

2 officers/directors

Cluster buy

Srinivasan Priya, Nabi Sue

290,000

$1.1M

SEC filings
6LKQ

LKQ CORP

3 officers/directors

Cluster buy

Urbain Xavier, CLARKE ANDREW C, Jude Justin L

25,669

$820K

SEC filings
7FEAM

5E Advanced Materials, Inc.

2 officers/directors

Cluster buy

Ascend Global Investment Fund SPC - Strategic Segregated Portfolio, BEP Special Situations IV LLC

200,000

$700K

SEC filings
8CLDI

Calidi Biotherapeutics, Inc.

2 officers/directors

Cluster buy

Schoeneck James A, Leftwich Scott

200,000

$400K

SEC filings
9TYG

TORTOISE ENERGY INFRASTRUCTURE CORP

10% Owner

PRUDENTIAL FINANCIAL INC

1,500,000

$15.0M

SEC filings
10AFCG

Advanced Flower Capital Inc.

Director

TANNENBAUM LEONARD M

849,673

$3.8M

SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.